Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
To describe the clinical characteristics and outcomes of patients with dual-phenotype hepatocellular carcinoma (DPHCC) and investigate the use of radiomics to establish an image-based signature for preoperative differential diagnosis.
This study included 50 patients with a postoperative pathological diagnosis of DPHCC (observation group) and 50 patients with CK7- and CK19-negative HCC (control group) who attended our hospital between January 2015 and December 2018. All patients underwent Gd-EOB-DTPA-enhanced MRI within 1 month before surgery. Arterial phase (AP), portal venous phase (PVP), delayed phase (DP) and hepatobiliary phase (HBP) images were transferred into a radiomics platform. Volumes of interest covered the whole tumor. The dimensionality of the radiomics features were reduced using LASSO. Four classifiers, including multi-layer perceptron (MLP), support vector machines (SVM), logistic regression (LR) and K-nearest neighbor (KNN) were used to distinguish DPHCC from CK7- and CK19-negative HCC. Kaplan–Meier survival analysis was used to assess 1-year disease-free survival (DFS) and overall survival (OS) in the observation and control groups.
The best preoperative diagnostic power for DPHCC will likely be derived from a combination of different phases and classifiers. The sensitivity, specificity and accuracy of LR in PVP (0.740, 0.780, 0.766), DP (0.893, 0.700, 0.798), HBP (0.800, 0.720, 0.756) and MLP in PVP (0.880, 0.720, 0.798) were better performance. The 1-year DFS and OS of the patients in the observation group were 69% and 78%, respectively. The 1-year DFS and OS of the patients in the control group were 83% and 85%, respectively. Kaplan–Meier survival analysis showed no statistical difference in DFS and OS between groups (P = 0.231 and 0.326), but DFS and OS were numerically lower in patients with DPHCC.
The radiomics features extracted from Gd-EOB-DTPA-enhanced MR images can be used to diagnose preoperative DPHCC. DPHCC is more likely to recur and cause death than HCC, suggesting that active postoperative management of patients with DPHCC is required.
Bosman FT, World HO, International AFRO (2010) WHO classification of tumours of the digestive system. International Agency for Research on Cancer, Lyon
Chen S, Feng S, Wei J et al (2019) Pretreatment prediction of immunoscore in hepatocellular cancer: a radiomics-based clinical model based on Gd-EOB-DTPA-enhanced MRI imaging. Eur Radiol 29:4177–4187 CrossRef
Chinese Society of Liver Cancer, Chinese Anti-Cancer Association, Liver Cancer Study Group, Chinese Society of Hepatology, Chinese Medical Association, Chinese Society of Pathology, Chinese Anti-Cancer Association et al (2015) Evidence based practice guidelines for the standardized pathological diagnosis of primary liver cancer in China (2015 update). Chin J Clin Hepatol 31:833–839
Cong WM, Bu H, Chen J et al (2016) Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 update. World J Gastroenterol 22:9279–9287 CrossRef
Esterson YB, Flusberg M, Oh S et al (2015) Improved parenchymal liver enhancement with extended delay on Gd-EOB-DTPA-enhanced MRI in patients with parenchymal liver disease: associated clinical and imaging factors. Clin Radiol 70:723–729 CrossRef
Gao F, Yan B, Zeng L et al (2019) Quantitative analysis of hepatocellular carcinomas pathological grading in non-contrast magnetic resonance images. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 36:581–589 PubMed
Guo D, Gu D, Wang H et al (2019) Radiomics analysis enables recurrence prediction for hepatocellular carcinoma after liver transplantation. Eur J Radiol 117:33–40 CrossRef
Huang X, Cheng Z, Huang Y et al (2018) CT-based radiomics signature to discriminate high-grade from low-grade colorectal adenocarcinoma. Acad Radiol 25:1285–1297 CrossRef
Kim S, Shin J, Kim DY et al (2019) Radiomics on gadoxetic acid-enhanced magnetic resonance imaging for prediction of postoperative early and late recurrence of single hepatocellular carcinoma. Clin Cancer Res 25:3847–3855 CrossRef
Lambin P, Rios-Velazquez E, Leijenaar R et al (2012) Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer 48:441–446 CrossRef
Lee JI, Lee JW, Kim JM et al (2012) Prognosis of hepatocellular carcinoma expressing cytokeratin 19: comparison with other liver cancers. World J Gastroenterol 18:4751–4757 CrossRef
Lee CW, Kuo WL, Yu MC et al (2013) The expression of cytokeratin 19 in lymph nodes was a poor prognostic factor for hepatocellular carcinoma after hepatic resection. World J Surg Oncol 11:136 CrossRef
Lee G, Bak SH, Lee HY et al (2019) Measurement variability in treatment response determination for non-small cell lung cancer: improvements using radiomics. J Thorac Imaging 34:103–115 CrossRef
Li L, Wang H (2015) Heterogeneity of liver cancer and personalized therapy. Cancer Lett 379:191–197 CrossRef
Liu LZ, Yang LX, Zheng BH et al (2018) CK7/CK19 index: a potential prognostic factor for postoperative intrahepatic cholangiocarcinoma patients. J Surg Oncol 117:1531–1539 CrossRef
Oyama A, Hiraoka Y, Obayashi I et al (2019) Hepatic tumor classification using texture and topology analysis of non-contrast-enhanced three-dimensional T1-weighted MR images with a radiomics approach. Sci Rep 9:8764 CrossRef
Sequist LV, Waltman BA, Dias-Santagata D et al (2011) Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors. Sci Transl Med 3:26r–75r CrossRef
Tanimoto A, Higuchi N, Ueno A (2012) Reduction of ringing artifacts in the arterial phase of gadoxetic acid-enhanced dynamic MR imaging. Magn Reson Med Sci 11:91–97 CrossRef
Torre LA, Bray F, Siegel RL et al (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87–108 CrossRef
Zhao W, Liu W, Liu H et al (2018) Preoperative prediction of microvascular invasion of hepatocellular carcinoma with IVIM diffusion-weighted MR imaging and Gd-EOB-DTPA-enhanced MR imaging. PLoS One 13:e197488
- Radiomics for diagnosis of dual-phenotype hepatocellular carcinoma using Gd-EOB-DTPA-enhanced MRI and patient prognosis
- Springer Berlin Heidelberg
Neu im Fachgebiet Onkologie
Mail Icon II